The initiative, which took effect September 1 for eligible Medicaid members, aggregates medical oncology, chemotherapy, immunotherapy, and high-tech imaging like MRIs into one request via the Eviti portal. This shift addresses a primary pain point identified in the company’s recent provider survey, where 74% of respondents cited administrative volume as their greatest clinical challenge. Nearly a third of those surveyed pointed specifically to the management of prior authorizations as the most significant contributor to their daily workload.

Katerina Guerraz, Aetna’s Chief Operating Officer and President of Medicaid, emphasized that the goal is to shift the focus from paperwork to patient outcomes. By approving broader treatment sets upfront, oncologists gain the flexibility to adjust care plans without triggering repeated approval cycles. Internal projections suggest the change could save 80% of providers at least 30 minutes of administrative time each day. Following the current Medicaid roll-out in states including Oklahoma, Illinois, and New Jersey, Aetna plans to extend this bundled authorization model to its Medicare and commercial lines of business during the first half of 2027.